Cleared Traditional

K770743 - SOLUSET FOR IV FAT EMULSION

K770743 is an FDA 510(k) clearance for SOLUSET FOR IV FAT EMULSION, manufactured by Abbott Laboratories. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K770743 · Abbott Laboratories · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1977
Decision
63d
Days
Class 2
Risk

K770743 is an FDA 510(k) clearance for the SOLUSET FOR IV FAT EMULSION. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 24, 1977 after a review of 63 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K770743

510(k) Number K770743 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 1977
Decision Date June 24, 1977
Days to Decision 63 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 129d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K770743.
I.V. PUMP SET FOR FAT EMULSION
K771593 · Abbott Laboratories · Sep 1977
FLUID HANDLING DEVICE W/INPUT TUBING
K771453 · Imed Corp. · Aug 1977
SURFLO WINGED INFUSION SET
K771204 · Terumo America, Inc. · Jul 1977
BURETTE SET, 2C0132
K770763 · Travenol Laboratories, S.A. · Jun 1977
IV SET THAT REVERTS TO KVO RATE
K770744 · Abbott Laboratories · May 1977
FILTER, INTRAVENOUS W/AUTO AIR VENT
K770589 · Jelco Laboratories · May 1977